1. Home
  2. TSAT vs CSTL Comparison

TSAT vs CSTL Comparison

Compare TSAT & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telesat Corporation

TSAT

Telesat Corporation

HOLD

Current Price

$47.69

Market Cap

697.5M

Sector

Industrials

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$24.53

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSAT
CSTL
Founded
1969
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.5M
806.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
TSAT
CSTL
Price
$47.69
$24.53
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$37.00
$45.50
AVG Volume (30 Days)
188.5K
260.7K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
N/A
$2.42
Revenue Next Year
N/A
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$14.81
$14.59
52 Week High
$55.69
$44.28

Technical Indicators

Market Signals
Indicator
TSAT
CSTL
Relative Strength Index (RSI) 58.77 45.05
Support Level $22.04 $21.77
Resistance Level N/A $26.44
Average True Range (ATR) 3.55 1.11
MACD 0.01 0.23
Stochastic Oscillator 40.62 54.91

Price Performance

Historical Comparison
TSAT
CSTL

About TSAT Telesat Corporation

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: